Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IMU-201 |
Trade Name | |
Synonyms | IMU-201/Montanide Vaccine |
Drug Descriptions |
IMU-201 (PD1-Vaxx) is a cancer vaccine comprising a fusion peptide of a B-cell epitope derived from PD-1 (PDCD1) and a T-cell epitope derived from the measles virus fusion protein, which potentially induces an antitumor immune response (PMID: 35646678). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C178425 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + IMU-201 | Atezolizumab IMU-201 | 0 | 1 |
IMU-201 | IMU-201 | 0 | 1 |